Status:
UNKNOWN
A Time-lapse Monitoring Prospective Study
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Aneuploidy
Infertility
Eligibility:
FEMALE
18-40 years
Brief Summary
While numerous types of commercially available human embryo culture media exist for human blastocyst culture, the impact of culture conditions on blastocyst development and aneuploidy formation is not...
Detailed Description
The use of extended embryo culture to the blastocyst stage and PGT-A has enabled identification and selection of embryos with the best developmental potential and improved IVF clinical outcomes. It is...
Eligibility Criteria
Inclusion
- Patients with a minimum of 8 - 10 follicles during ovarian stimulation
- Patients with a minimum of 8 mature oocytes
- PGT-A
- ICSI
- BMI\<35
- Age 18- 40
- Fresh or frozen ejaculatory sperm \>10,000 motile sperm
- Any Ovarian stimulation
- Embryos cultured in Time-lapse system
Exclusion
- PGT-M or PGT-SR
- Previous history of embryo arrest
- Endometriosis
- Hydrosalpinx
- History of uterine abnormality or previous uterine surgery
- History of previous treatment which may impact the ovarian reserve (adnexal surgery, chemotherapy, radiation…)
Key Trial Info
Start Date :
July 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04901247
Start Date
July 6 2021
End Date
December 30 2023
Last Update
March 24 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ART Fertility Clinics
Abu Dhabi, United Arab Emirates
2
Ibrahim Elkhatib
Abu Dhabi, United Arab Emirates